Diagnostics

ITM, Helmholtz Munich and the University of Münster Announce Updated Preliminary Phase 1 Data with ITM-31 in Glioblastoma Patients

Patient enrollment has been completed; all enrolled patients remain aliveData presented at the Nuclear Medicine and Neuro-Oncology (NMN) Society Annual...

Days After Launch, Attunio Health Expands Precision Psychiatry Infrastructure with Quest Diagnostics and Getlabs

Quest Diagnostics and Getlabs strengthen Attunio's AI-powered, biomarker-driven infrastructure with blood and genetic testing from homeATLANTA, June 25, 2026 /PRNewswire/...

Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening Leadership Position in Fast-Growing Life Sciences Markets

Purchase price of US$73 per share in cash represents an enterprise value of US$11.3 billion (EUR 9.9 billion)Proposed acquisition expected to be immediately accretive to...

Circulate Health announces exclusive partnership with Reborne to bring its advanced therapeutic plasma exchange protocols to UK for first time

LONDON, June 25, 2026 /PRNewswire/ -- Circulate Health and Reborne have today announced an exclusive partnership that will see Reborne become...

Noom Launches Free Version of Its Powerful GLP-1 Companion — Empowering Providers with a Research-Backed Tool to Support Weight Loss That Lasts

Providers can now offer their GLP-1 patients a free, structured support program for nutrition, side effects, muscle health, movement, mindset,...

error: Content is protected !!